Suchergebnisse - "Martora, F"

PubPharm (22)

1

Allergic contact dermatitis to petrolatum : An unknown for patch testing

enthalten in: Contact dermatitis | 2024

von Napolitano, M. | Martora, F. | Antelmi, A. | +4

2

Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study

in: Clinical, Cosmetic and Investigational Dermatology | 2024

von Martora F | Marasca C | Cacciapuoti S | +5

3

Long-Term Efficacy of Guselkumab in an Adolescent Hidradenitis Suppurativa Patients: A Case Report

in: Clinical, Cosmetic and Investigational Dermatology | 2024

von Martora F | Battista T | Potestio L | +3

4

Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review

in: Clinical, Cosmetic and Investigational Dermatology | 2024

von Potestio L | Martora F | Cacciapuoti S | +3

5

Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection

in: Clinical, Cosmetic and Investigational Dermatology | 2023

von Potestio L | Piscitelli I | Fabbrocini G | +3

6

Herpes Zoster and COVID-19 Vaccination: A Narrative Review

in: Clinical, Cosmetic and Investigational Dermatology | 2023

von Potestio L | Megna M | Villani A | +3

7

Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data

in: Clinical, Cosmetic and Investigational Dermatology | 2023

von Martora F | Scalvenzi M | Battista T | +4

8

A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab

in: Clinical, Cosmetic and Investigational Dermatology | 2023

von Megna M | Ruggiero A | Salsano A | +5

9

Reply to 'Cutaneous adverse effects of the available COVID-19 vaccines in India : A questionnaire-based study' by Bawane J et al

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2022

von Potestio, L. | Genco, L. | Villani, A. | +5

CommentOn: J Eur Acad Dermatol Venereol. 2022 Aug;36(8):e619-e622. - PMID 35429053

10

Reply to 'Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2' by Solimani et al

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2022

von Martora, F. | Fabbrocini, G. | Nappa, P. | +1

CommentOn: J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e649-e651. - PMID 34169588